Coronavirus (COVID-19) Collection
A localised vasculitic-like skin rash following the second dose of COVID-19 vaccine
Since December 2020, a number of different types of COVID-19 vaccines have been developed to limit the spread of the pandemic [Jedlowski et al., 2021]. Although there have been reported side effects and adverse reactions to COVID-19 vaccines, they are still considered safe as the benefits of halting the spread of the virus and reducing the severity of COVID-19 infection outweigh the risks. Skin rash and reactions have been reported as possible side effects associated with different types of COVID-19 vaccines.Pityriasis Rosea Shortly After mRNA-1273 COVID-19 Vaccination
With the increase in rates of vaccination against COVID-19, various cutaneous reactions have been reported after vaccination, including pityriasis rosea (PR) (Catala et al., 2021; Johansen et al., 2021; Marcantonio-Santa Cruz et al., 2021; McMahon et al., 2021). It is easy to overlook because the incidence of PR as a side effect of COVID-19 vaccination is extremely low, accounting for about 0.96% of all cutaneous reactions (McMahon et al., 2021).New style for nasopharyngeal swab with a mask: image-evaluation
COVID-19, caused by SARS-CoV-2, is rapidly spreading worldwide and has become a threat to humankind. Respiratory infectious viruses such as SARS-CoV-2 are transmitted via contact and droplets and have a high secondary attack rate ranging from 3.0%–11.2% in households (Wiersinga et al., 2020). Diagnosis of respiratory infectious virus is performed by collecting specimens from the surface of the respiratory mucosa using nasopharyngeal swabs (Föh et al., 2020; Marty et al., 2020). However, it is a high-risk procedure for healthcare workers because it causes pharyngeal reflexes or sneezing.Transient perivascular inflammation of the carotid artery (TIPIC) syndrome in a patient with COVID-19
A 36-year-old man with moderate-to-severe left neck pain, local swelling, and tenderness was seen at the emergency room. Over the prior 4 days he had received beta-lactam antibiotic therapy with no improvement. One month before he experienced mild symptomatic coronavirus disease 2019 (COVID-19). The PCR-based test performed at the emergency room was still positive. The remaining personal history was negative. The routine laboratory parameters were within reference range and autoimmunity screening results were negative (Table 1).Clinical course of alopecia after COVID-19
A 49-year-old man was admitted to our hospital in late March 2020, 6 days after onset of coronavirus disease 2019 (COVID-19). He received remdesivir in a clinical study. Oxygen supplementation was not required. Defervescence occurred 12 days after onset, and he was discharged 21 days after symptom onset. In mid-May 2020, he noticed alopecia on his head. He started taking self-imported minoxidil 5 mg/day and finasteride 1 mg/day in June 2020, and was still taking these medications at the time of writing.A case of rapidly progressive upper limb ischemic necrosis in a patient with COVID-19
For more than a year, health systems all over the world have been combating the global coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease was first described in the city of Wuhan in China, presenting as an atypical infection of the lower respiratory tract.Aortic thrombosis in a patient with COVID-19-associated hyperinflammatory syndrome
A 77-year-old man was admitted for severe PCR-confirmed COVID-19. The patient presented with severe hypoxemia and biological findings suggestive of a hyperinflammatory syndrome: severe lymphopenia in combination with signs of hypercytokinemia (elevated C-reactive protein), coagulopathy (elevated D-dimer levels), and hepatic injury (elevated lactate dehydrogenase) (Webb et al., 2020).Bilateral cotton wool spots after ambulatory COVID-19
A 55-year-old male with a history of paroxysmal atrial fibrillation and pre-hypertension tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after presenting with fever, headache, body aches, and cough. Symptoms lasted for 10 days. A dilated fundus examination, 3 weeks after the onset of symptoms, revealed cotton wool spots (CWS) in both eyes with superficial flame-shaped hemorrhage in the right eye (Figure 1). Fluorescein angiography exhibited normal arterial and venous filling without capillary dropouts or signs of retinopathy.Purple urine in a patient after recovery from a SARS-CoV-2 infection
A 96-year-old woman living in a nursing home was admitted to the university hospital Erlangen due to an infection with SARS-CoV-2. She presented with fever, coughing and reduced general condition. Under symptomatic therapy, the patient's condition improved. After 2 weeks, she developed fever again, and her urine turned purple (Figure 1).Periungual desquamation in a Japanese Adult recovering from severe COVID-19
A 50-year-old Japanese man was admitted to our hospital with a 14-day history of fever and sudden dyspnea. The patient was diagnosed with severe coronavirus disease (COVID-19) based on positive test results of RNA polymerase chain reaction for severe acute respiratory syndrome coronavirus. He was started on mechanical ventilation and extracorporeal membrane oxygenation (ECMO). He received ECMO for 23 days and was tracheostomized on hospital day (HD) 37. His general condition improved by HD 54. On HD 61, periungual desquamation appeared on the fingers of left hand (Panel 1A), left palm (Panel 1B), and both feet (Panel 1C).Destructive pulmonary fibrosis after severe COVID-19 pneumonia
A 65-year-old man was admitted to the intensive care unit (ICU) of Tenon hospital, a university teaching hospital in Paris, France, for severe confirmed COVID-19 pneumonia. He had a history of diabetes. In the preceding week, the patient developed fever (39 °C), cough, and shortness of breath. A chest computed tomography (CT) scan showed bilateral ground glass opacities with alveolar consolidation (Figure 1A) predominant in the lung periphery as usually reported in COVID-19 pneumonia (Chung et al.Concurrent COVID-19 and Pneumocystis jirovecii pneumonia in a severely immunocompromised 25-year-old patient
A 25-year-old male presented with profound hypoxemia despite use of a non-rebreather mask during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Chest X-ray showed a large right pneumothorax and extensive interstitial disease (Figure 1a). Hypoxemia continued despite chest tube placement, necessitating emergent intubation. Computed tomography (CT) of the chest (Figure 1b–d) was obtained and nasopharyngeal SARS-CoV-2 PCR was positive. HIV serology was positive and his absolute CD4+ count was 32 cells/mm3.Encephalopathy in severe SARS-CoV2 infection: Inflammatory or infectious?
The appearance of SARS-CoV2 was described in December 2019 in China, but it was not until March 2020 when the pandemic reached Spain. Although this virus mainly presents a respiratory involvement, we have observed the appearance of neurological symptoms (headache, myalgia, hyposmia/anosmia, dysgeusia, insomnia) and diseases (stroke, encephalitis, or Guillain-Barré syndrome) (Mao et al., 2020; Li et al., 2020; Helms et al., 2020; De Melo Espíndola et al., 2020).Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations?
Some oral manifestations have been observed in patients with coronavirus disease 2019 (COVID-19). However, there is still a question about whether these lesions are due to coronavirus infection or secondary manifestations resulting from the patient's systemic condition. Thus, this article aims to report an additional case of an oral condition in a patient diagnosed with COVID-19. Our patient, a sixty-seven-year-old Caucasian man, tested positive to coronavirus and presented oral manifestations such as recurrent herpes simplex, candidiasis, and geographic tongue.Acute pulmonary embolism mimicking COVID – 19 pneumonia
An 81-year-old woman was admitted to the emergency department with reduced general condition and diarrhea for 2 weeks. Physical examination, sonography of the abdomen and ECG showed no pathologies. Fever was not present. Peripheral O2-saturation was 86%. Laboratory test showed an infection constellation.Viral exanthem with “Spins and needles sensation” on extremities of a COVID-19 patient: A self-reported case from an Indonesian medical frontliner
Cutaneous manifestation is a newly reported clinical manifestation of COVID-19 infection. The clinical description of cutaneous manifestation is still not fully described. Our patient, a medical person, had viral exanthem distributed in the extremities along with a “Spins and needles sensation,” which differs from a previously published paper on cutaneous manifestations. The differential diagnosis of drug-induced skin rash and hand-foot-mouth disease was ruled out based on the patient's previous history and course of the disease.
